Stephen David Prior - 03 Jan 2025 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Signature
/s/ Lucy Day, Attorney-in-Fact for Stephen David Prior
Issuer symbol
ANTX
Transactions as of
03 Jan 2025
Net transactions value
-$2,721
Form type
4
Filing time
07 Jan 2025, 19:57:18 UTC
Previous filing
05 Nov 2024
Next filing
28 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale $2,721 -2,029 -5.7% $1.34 33,313 03 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
F2 Includes (a) 10,125 RSUs which shall vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 and (b) 12,031 RSUs which shall vest on January 1, 2026, in each case, subject to the Reporting Person continuing to provide services to the Company as an employee, consultant or director of the Company through each applicable vesting date.